Interim Order
at Himachal Pradesh High Court
14 interim order decisions from Himachal Pradesh High Court.
Interim Order Decisions
14 cases | Page 1 of 1
Boehringer Ingelheim International GmbH v.Eris Lifesciences Limited
The plaintiffs, Boehringer Ingelheim (through its Power of Attorney Holder), filed an application seeking interim relief against Eris Lifesciences Limited. The dispute centers on the alleged infringement of Indian Patent No. 268846 by the defendant's manufacturing and sale of generic versions of Empagliflozin and related formulations, including products sold under the trade mark 'Linares-E'.
Boehringer Ingelheim International GmbH v.Eris Lifesciences Limited
The plaintiffs, represented by Boehringer Ingelheim International GmbH and its Indian subsidiary, sought an interim injunction against Eris Lifesciences Limited for allegedly infringing their Indian Patent No. 268846 related to Empagliflozin. The court found that the plaintiffs had established a prima facie case and balance of convenience, leading to the grant of temporary relief.
Boehringer Ingelheim International GmbH v.Eris Lifesciences Limited
The plaintiffs, Boehringer Ingelheim International GmbH (through its Power of Attorney Holder), filed an application seeking interim relief against Eris Lifesciences Limited for infringing Indian Patent No. 268846. The patent covers pharmaceutical products like Empagliflozin and related formulations. The court found that the plaintiffs had established a prima facie case, leading to the grant of an injunction.
Boehringer Ingelheim International GmbH v.Eris Lifesciences Limited
The plaintiffs, Boehringer Ingelheim (through its Power of Attorney Holder), filed an application seeking an interim injunction against Eris Lifesciences Limited. The suit concerns alleged infringement of Indian Patent No. 268846 related to the medicinal product Empagliflozin and its formulations. The court found that the plaintiffs had established a prima facie case and granted the requested restraint.
Sml Ltd. v.M/S Happy Agro Chemicals & Ors.
SML Ltd. filed a commercial suit seeking protection against the infringement of its patent (IN 282092) by M/S Happy Agro Chemicals & Ors., specifically concerning their product 'SELZIC'. The court, after considering arguments and expert testimony, found that a prima facie case was made out.
Sml Ltd. v.M/S Happy Agro Chemicals & Ors.
SML Ltd. filed a commercial civil suit seeking protection against infringement of its patent (IN282092) by M/S Happy Agro Chemicals & Ors., who market the product 'ZINKING'. The court, after considering submissions and expert reports, found that a prima facie case was made out.
Sml Limited v.Mohan & Company & Another
Sml Limited filed a suit alleging that defendants are manufacturing and selling a fertilizer product named Zeeka Sulf, which infringes upon its Indian Patent No. IN 282092. The plaintiff provided chemical analysis reports and expert opinions confirming that the composition of Zeeka Sulf falls within the scope of the patented claims.
Sml Limited v.Mohan & Company & Another
Sml Limited filed a suit alleging that defendants are manufacturing and selling a fertilizer composition named 'Aladdin' which infringes upon its granted Indian Patent No. IN 282092. Chemical analysis confirmed the defendant's product contained sulphur (67.8%) and zinc oxide (22.7%), falling within the patented range. The court found a prima facie case of infringement.
Janssen Pharmaceuticals Inc And Others v.Clevus Lifesciences and others
The plaintiffs, exclusive licensees of the patent holder for Indian Patent No. 232231, filed a suit alleging infringement by defendant No. 1 and others who were manufacturing and offering Canagliflozin tablets under brand names like Adkana. The court found a prima facie case in favor of the plaintiffs.
Janssen Pharmaceuticals & Others v.MSN Laboratories Pvt. Ltd.
The plaintiffs, patent holders of Indian Patent No. 312847 covering a combination therapy for diabetes (Metformin + Canagliflozin), filed suit against the defendant for infringement. The court found that a prima facie case was made out in favor of the plaintiffs and granted an ad interim injunction restraining the defendant from manufacturing or marketing the infringing product.
Janssen Pharmaceuticals & Others v.MSN Laboratories Pvt. Ltd.
Plaintiffs, exclusive licensees of a patent holder (Mitsubishi Tanabe Pharma Corporation), filed suit alleging that Defendant No. 1 was manufacturing and marketing Canagliflozin Tablets/Capsules, which falls under Indian Patent No. 232231. The defendant opposed the interim injunction, arguing that damages could be quantified and there was no irreparable loss. The court found a prima facie case in favor of the plaintiffs.
Jansen Pharmaceuticals & Others v.Aeon Formulations Pvt. Ltd.
The plaintiffs, who are exclusive licensees of the patent holder (Mitsubishi Tanabe Pharma Corporation), filed a suit alleging that Defendant No. 1 was manufacturing and marketing Canagliflozin Tablets/Capsules, thereby infringing Indian Patent No. 232231. The court found a prima facie case in favor of the plaintiffs.
Boehinder Pharma v.Macleods Pharma
Boehinder Pharma filed an application seeking ad-interim relief to restrain Macleods Pharma from infringing its patent rights over 'Linagliptin'. The applicants argued that their patent was still valid and the respondent was manufacturing and selling the product under brands LINAMAC and LINAONE. The court, finding a prima facie case, granted an interim injunction restraining the respondent from manufacturing or selling Linagliptin.
Plaintiff No. 1 v.Defendants
The plaintiffs, owners of two patents covering the compound LINAGLIPTIN and its derivatives, filed a suit alleging that the defendants were manufacturing LINAGLIPTIN tablets under the brand name BRLENTA-5 without consent. The court found a prima facie case for injunction.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.